Otitis media, or chronic middle ear infection, is one of the most common causes of childhood visits to the ENT department. Although antibiotics have been a conventional western treatment, the emergence of antibiotic-resistant bacteria is now a serious and growing problem.
Research at Columbia Presbyterian is aimed at providing our young patients with the most effective, safe therapies.
In his work on otitis media, Dr. Haddad is particularly interested in the effects of antibiotics and the development of antibiotic-resistant bacteria.
Dr. Haddad's experience researching otitis media includes numerous research projects. A very few of these include:
* Study of Ciprofloxacin in the Treatment of Acute Otitis Media with Tympanostomy Tubes, 2000
* Study of Azithromycin in children undergoing Tympanocentesis, 2000
* Study of Augmentin in infants and children, 1998- 1999
* Study of Ofloxacin in children after tympanostomy, 1996 - 1997
* Resistant Pneumococcus in Otitis Media, 1995 - 1996
* Comparison study of Loracarbef versus Clarithromycin in Acute Otitis Media with Effusion, 1995 - 1996 |